Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Manufacturing
Cellares attracts $257M series D to build sites in Japan, Europe
With Cellares preparing to begin commercial production in 2027, the cell therapy contract manufacturer has raised $257 million in a series D round.
Kevin Dunleavy
Jan 28, 2026 9:40am
Cellares expands to Europe with new facility in the Netherlands
Jan 12, 2026 2:24pm
Orca rides $250M funding wave toward cancer cell therapy launch
Jan 9, 2026 11:19am
Acuitas takes majority stake in Montreal-based RNA manufacturer
Jan 8, 2026 9:12am
FDA signs off on 1st gene therapy for rare genetic disease
Dec 10, 2025 12:09pm
Novartis scores FDA approval for new version of SMA gene therapy
Nov 25, 2025 10:02am
